What is the role of adipokines in myasthenia gravis?

OBJECTIVE: Myasthenia gravis (MG) is a disease with autoimmune etiology. The main pathomechanism is related to the production of antibodies against nicotinic acetylcholine receptor. The present study is aimed to compare the serum level of adipokines in patients with MG with that in controls, as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozmilowska, Izabela, Czyzewski, Damian, Mazur, Bogdan, Adamczyk-Sowa, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118871/
https://www.ncbi.nlm.nih.gov/pubmed/30214215
http://dx.doi.org/10.2147/TCRM.S163966
Descripción
Sumario:OBJECTIVE: Myasthenia gravis (MG) is a disease with autoimmune etiology. The main pathomechanism is related to the production of antibodies against nicotinic acetylcholine receptor. The present study is aimed to compare the serum level of adipokines in patients with MG with that in controls, as well as to study the relation of these levels with disease severity. PATIENTS AND METHODS: Fifty patients with MG and 30 healthy individuals were enrolled in our study. Serum concentrations of select adipokines, namely adiponectin, leptin, omentin, visfatin, and resistin were measured. RESULTS: The results showed a significant increase in serum concentrations of adiponectin and resistin in the patients with MG compared with the controls. CONCLUSION: Further studies are warranted to assess changes in adipokine concentration levels in patients with MG.

Ejemplares similares